Predictors of bleeding risk and long-term mortality in patients with acute coronary syndromes
- 21 February 2005
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 21 (3) , 439-445
- https://doi.org/10.1185/030079905x30725
Abstract
Objective: The aim of this review was to collate the published evidence on independent predictors of bleeding and late mortality in acute coronary syndrome (ACS) patients, to compare the two sets of risk factors, and to investigate whether bleeding is reported as a predictor of late mortality. Research design and methods: Computerized searches, covering the period from 1999 to July 2004, were performed on MEDLINE, EMBASE, and the Cochrane Library database. Studies were eligible for inclusion in the review if they related to patients with ACS and included an assessment of risk factors for bleeding, mortality, or both. Studies that did not meet these criteria were excluded. Main outcome measures: A total of 937 studies were retrieved, of which 912 were excluded from the review because they did not meet the defined criteria. Results: The available evidence suggests that any impact of bleeding on mortality is confined to the short term. In studies that showed a significant association between bleeding and risk of mortality, this was always related to in-hospital or 30-day mortality. By contrast, studies of long-term mortality consistently showed that bleeding was not an independent predictor. Furthermore, follow-up studies showed that adverse outcomes in hospital and within the first month were not related to 1-year mortality. This may reflect the beneficial impact of anticoagulant therapy on subsequent cardiovascular risk in patients with ACS, which outweighs any short-term detrimental effect of bleeding. Conclusions: The available evidence suggests that any impact of bleeding on mortality in ACS patients appears to be confined to the short term, and long-term outcomes do not reflect the impact of in-hospital bleeding.Keywords
This publication has 14 references indexed in Scilit:
- Anti-Xa Activity Relates to Survival and Efficacy in Unselected Acute Coronary Syndrome Patients Treated With EnoxaparinCirculation, 2004
- Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the assessment of the safety of a new thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarctionAmerican Heart Journal, 2004
- Bleeding events with abciximab in acute coronary syndromes without early revascularization: an analysis of GUSTO IV–ACSAmerican Heart Journal, 2004
- Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary SyndromeChest, 2004
- Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventionsThe American Journal of Cardiology, 2003
- Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)European Heart Journal, 2003
- The dilemma of success: Percutaneous coronary interventions in patients ≥ 75 years of age—successful but associated with higher vascular complications and cardiac mortalityCatheterization and Cardiovascular Interventions, 2003
- ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction—2002: Summary ArticleCirculation, 2002
- abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profileThe American Journal of Cardiology, 2002
- Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials)The American Journal of Cardiology, 2000